「anti-cancer drug」を含む例文一覧(20)

  • a type of anti-cancer drug, called {alkylate drug}
    アルキル化剤という抗癌剤 - EDR日英対訳辞書
  • Mitomycin is an anti-cancer drug.
    マイトマイシンは抗がん剤だ。 - Weblio英語基本例文集
  • SENSITIVITY EVALUATING METHOD FOR ANTI-CANCER DRUG, AND DEVICE THEREFOR
    抗ガン剤の感受性評価方法およびその装置 - 特許庁
  • a nonsteroidal anti-inflammatory drug (nsaid) that is being studied as a treatment for cancer.
    がんの治療薬として研究中の非ステロイド性抗炎症薬（nsaid）。 - PDQ®がん用語辞書 英語版
  • To provide an anticancer drug containing an anti-PD-1 antibody or an anti-PD-L1 antibody, which can be used very favorably for treating cancer, particularly metastatic cancer.
    癌、特に転移性癌の治療に非常に有用に使用できる、抗ＰＤ−１抗体または抗ＰＤ−Ｌ１抗体を含む抗癌剤の提供。 - 特許庁
  • An infusion agent to a pancreas artery containing an anticancer drug and a contrast agent is combined with an anti-pancreas-cancer drug for systemic administration.
    制癌剤および造影剤を含有する膵動脈注入剤と全身投与用の抗膵癌剤との組合せからなる。 - 特許庁
  • To remakably reduce a time required from collection of a cancer cell upto selection of an optimum anti-cancer drug.
    ガン細胞を採取してから、最適の抗ガン剤の選択ができるまでの所要時間を大幅に短縮する。 - 特許庁
  • To provide a novel cancer inspection method and a novel anti-cancer drug screening method.
    本発明は新規の癌の検査方法及び新規の抗癌剤のスクリーニング方法の提供を目的とする。 - 特許庁
  • USE OF MURINE GENOMIC REGION IDENTIFIED TO BE INVOLVED IN TUMOR DEVELOPMENT FOR DEVELOPMENT OF ANTI-CANCER DRUG AND DIAGNOSIS OF CANCER
    抗癌剤の開発および癌の診断のための、腫瘍の発生に関与することが同定されたマウスゲノム領域の使用 - 特許庁
  • To provide a method for detecting the morbidity to a disease associated with DNA damage or cell death and measuring the treatment effect of an anti-cancer drug.
    ＤＮＡ損傷または細胞死をともなう疾患への罹患の検出および抗ガン剤治療の効果測定方法の提供。 - 特許庁
  • The method for treating cancer includes administration of effective amounts of an anti-VEGF antibody and an anti-malignant tumor composition to a patient, provided that the anti-malignant tumor composition contains at least one kind of a chemotherapeutic drug.
    患者に有効量の抗ＶＥＧＦ抗体及び抗悪性腫瘍組成物を投与することを含み、上記抗悪性腫瘍組成物が少なくとも一種の化学療法剤を含有する癌の治療方法。 - 特許庁
  • This method is one for inspecting the capability of cancer cells to propagate and also one for screening anti-cancer drug by detecting human Parbrine 14 (hereinafter referred to as 'hPar 14').
    本発明はヒトパルブリン１４（以下「ｈＰａｒ１４」）を検出することにより、癌細胞の増殖能力を検査する方法、更には抗癌剤をスクリーニングする方法に関する。 - 特許庁
  • To provide a food, a drug and the like which have estrogen-like action and can be used as an anti-osteoporosis agent, an agent for improving and treating climacteric disturbance, an agent for preventing and treating prostatic cancer, prostatic hypertrophy, breast cancer, and uterine cancer or an agent for improving and treating acne of female delayed puberty.
    エストロジェン様作用を有し、抗骨粗鬆症剤、更年期障害の改善・治療剤、前立腺癌・前立腺肥大症・乳癌及び子宮癌の予防・治療剤あるいは女性の思春期後発症のざ瘡改善・治療剤に有用な食品、医薬などを提供する。 - 特許庁
  • To provide a food, a drug and the like which have estrogen-like action and can be used as an anti-osteoporosis agent, an agent for improving and treating climacteric disturbance, an agent for preventing and treating prostatic cancer, prostatic hypertrophy, breast cancer, and uterine cancer or an agent for improving and treating acne of female delayed puberty.
    エストロジェン様作用を有し、抗骨粗鬆症剤、更年期障害の改善・治療剤、前立腺癌・前立腺肥大症・乳癌及び子宮癌の予防・治療剤あるいは女性の思春期後発症のざ瘡改善・治療剤に有用な食品、医薬などを提供すること。 - 特許庁
  • An estrogen substitute composition contains an ethanolic extract of mace, and the anti-osteoporosis agent, the agent for improving and treating climacteric disturbance, the agent for improving and treating prostatic cancer, prostatic hypertrophy, breast cancer, and uterine cancer, an agent for improving and treating acne of female delayed puberty, the food, the drug, and a cosmetic contain this estrogen substitute composition.
    メースのエタノール抽出物を含有するエストロジェン代替組成物、これを含む抗骨粗鬆症剤、更年期障害の改善・治療剤、前立腺癌・前立腺肥大症・乳癌及び子宮癌の予防・治療剤、女性の思春期後発症のざ瘡改善・治療剤、食品、医薬、化粧料。 - 特許庁
  • An estrogen substitute composition contains an ethanolic extract of the pollen of camellia and the anti-osteoporosis agent, the agent for improving and treating climacteric disturbance, the agent for improving and treating prostatic cancer, prostatic hypertrophy, breast cancer, and uterine cancer, an agent for improving and treating acne of female delayed puberty, the food, the drug, and a cosmetic contain this estrogen substitute composition.
    ツバキ花粉エタノール抽出物を含有するエストロジェン代替組成物、これを含む抗骨粗鬆症剤、更年期障害の改善・治療剤、前立腺癌・前立腺肥大症・乳癌及び子宮癌の予防・治療剤、女性の思春期後発症のざ瘡改善・治療剤、食品、医薬、化粧料。 - 特許庁
  • The morbidity to the disease associated with DNA damage or cell death is detected or the treatment effect of the anti-cancer drug is measured by measuring the concentration of ribosyl adenosine or ribosyl inosine in a biological specimen derived from an animal to be examined.
    被検動物から得た生物学的試料におけるリボシルアデノシンまたはリボシルイノシンの濃度を測定することにより、ＤＮＡ損傷または細胞死をともなう疾患への罹患を検出し、または抗ガン剤治療の効果を測定する。 - 特許庁
  • The following administration schedule of (1)-(3) is repeated at least two courses: (1) systemic administration of the anti-pancreas-cancer drug is performed once a week at least for three weeks, (2) the infusion agent to a pancreas artery is infused one time to small arteries around the pancreas under catheterization, and (3) the administration is halted at least for a week.
    下記(1)〜(3)の投薬スケジュールによる投与を、少なくとも２クール行う：(1)抗膵癌剤の全身投与を少なくとも３週間行う、(2)膵周囲小動脈へのカテーテリゼーション下での膵動脈注入剤の注入を１回行う、(3)少なくとも１週間投薬休止。 - 特許庁
  • To provide a drug delivery carrier into a tumor cell which comprises a region relating to the internalization of an anti-mortalin antibody into a tumor cell, by determining the region and its amino acid sequence, and to provide a region on the mortalin which interacts with the region relating to the internalization of an anti-mortalin antibody into a cancer cell and its amino acid sequence.
    抗モータリン抗体の腫瘍細胞への内在化機能に関与する領域とそのアミノ酸配列を決定し、当該領域を含む腫瘍細胞内への薬剤輸送キャリアを提供すること、及び抗モータリン抗体の癌細胞内在化機能に関与する領域と相互作用する、モータリン上の領域及びそのアミノ酸配列を提供する。 - 特許庁
  • The invention presents an internal therapeutic product comprising (i) an anti-cancer component selected from one or both of a radionucleotide and a cytotoxic drug and (ii) a silicon component selected from one or more of resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon and bulk crystalline silicon.
    (i)放射性ヌクレオチド、細胞毒性薬物の1つまたは双方から選ばれた抗癌成分；および(ii) 吸収性シリコン、生体適合性シリコン、バイオ活性シリコン、多孔質シリコン、多結晶質シリコン、非晶質シリコン、および体積結晶質シリコンの1種以上から選ばれたシリコン成分を含む内部治療用製品を提供する。 - 特許庁

例文データの著作権について